CME Information
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
Target Audience
The intended audience for this activity is retina specialists and other healthcare professionals involved in the management of patients with nAMD and DME.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Examine new strategies that increase treatment intervals of currently available injectable therapies in the treatment of nAMD and DME.
- Assess new clinical evidence regarding the efficacy, safety and real-world use of new injectable treatment regimens in patients with nAMD and DME.
Activity Chair
Rishi P. Singh, MD
Staff Physician and President
Cleveland Clinic Martin Hospitals
Stuart, FL
Professor of Ophthalmology, Lerner College of Medicine
Case Western Reserve University
Cleveland, OH
Faculty
Dilsher S. Dhoot, MD
Vitreoretinal Surgeon
California Retina Consultants / Retina Consultants of America
Santa Barbara, CA
Michael S. Ip, MD
Professor of Ophthalmology
Medical Director, Doheny Image Reading Center
Doheny Eye Institute
University of California – Los Angeles
Pasadena, CA
Planner/Reviewer
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, February 22, 2023, to February 21, 2024.
How to Participate in This Activity and Obtain CME Credit
To participate in this CME activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 of the 3 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
Activity Chair and Faculty report the following relevant financial relationship(s)
Dilsher S. Dhoot, MD
Consultant: Alimera, Allergan, Apellis, Bayer, Coherus, EyePoint, Genentech, Novartis, Regeneron, Regenxbio
Speaker Contracted by Ineligible Company: Alimera, Apellis, EyePoint, Genentech, Regeneron
Individual Stocks and Stock Options: Outlook Therapeutics, Vortex Surgical
Michael S. Ip, MD
Consultant: Alimera, Allergan, Amgen, Apellis, Clearside, Novartis, OccuRx, Regeneron
Rishi P. Singh, MD
Consultant: Alcon, Apellis, AsclepiX, Bausch + Lomb, Genentech, Gyroscope, Iveric Bio, Novartis, Regeneron
Planner/Reviewer reports the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2023 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com